RSS   Newsletter   Contact   Advertise with us
Post Online Media

Abpro appoints Gavin MacBeath as CSO

Gavin MacBeathAbpro, a therapeutic antibody company, announced the hiring of Gavin MacBeath as chief scientific officer.

Dr. MacBeath brings over 16 years of experience in academia and the biotechnology industry.

Dr. MacBeath comes to Abpro from Merrimack Pharmaceuticals, where he was a Founder and served most recently as Senior Vice President of Discovery and Head of Translational Medicine.

During this time, Dr. MacBeath also held a position as Lecturer / Principal Investigator in the Department of Systems Biology at Harvard Medical School, where he discovered new signaling pathways driving cancer metastasis.

Previously, Dr. MacBeath was an Associate Professor in the Department of Chemistry and Chemical Biology at Harvard University.

While at Harvard, he was a pioneer in Systems Biology, where he developed and used protein microarray technology to dissect aberrant signaling pathways in cancer.

Dr. MacBeath holds a Bachelor of Science Degree in Genetics from the University of Manitoba and a Ph.D. in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute.

 LATEST MOVES FROM Massachusetts 

More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy